| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 35.145 | 41.812 | - | 61.122 | 75.919 | - | 94.694 | - | - | - |
| Total Income - EUR | 35.145 | 41.812 | - | 61.126 | 76.341 | - | 94.694 | - | - | - |
| Total Expenses - EUR | 23.861 | 24.868 | - | 26.805 | 32.138 | - | 35.806 | - | - | - |
| Gross Profit/Loss - EUR | 11.284 | 16.944 | - | 34.321 | 44.203 | - | 58.888 | - | - | - |
| Net Profit/Loss - EUR | 10.241 | 16.526 | - | 33.765 | 43.440 | - | 58.049 | - | - | - |
| Employees | 4 | 0 | - | 3 | 3 | - | 2 | - | - | - |
Check the financial reports for the company - Ligiamed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | - | 0 | 505 | - | 37 | - | - | - |
| Current Assets | 11.730 | 28.152 | - | 80.055 | 84.438 | - | 114.184 | - | - | - |
| Inventories | 0 | 0 | - | 0 | 0 | - | 0 | - | - | - |
| Receivables | 2.960 | 23.779 | - | 65.414 | 34.427 | - | 39.369 | - | - | - |
| Cash | 8.770 | 4.373 | - | 14.641 | 50.011 | - | 74.816 | - | - | - |
| Shareholders Funds | 10.286 | 26.707 | - | 78.194 | 82.188 | - | 111.281 | - | - | - |
| Social Capital | 45 | 45 | - | 43 | 42 | - | 40 | - | - | - |
| Debts | 1.444 | 1.445 | - | 1.861 | 2.755 | - | 2.940 | - | - | - |
| Income in Advance | 0 | 0 | - | 0 | 0 | - | 0 | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Ligiamed Srl